NOTE 10 - SHARE-BASED COMPENSATION

9 Months Ended

Sep. 30, 2019

Share-based Payment Arrangement, Noncash Expense [Abstract]

NOTE 10 - SHARE-BASED COMPENSATION

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method. For these awards we have recognized compensation expense using a straight-line amortization method reduced for estimated forfeitures.

The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three and nine months ended September 30, 2019 and 2018, respectively, was as follows:

	Three Months Ended				Nine Months Ended
	September 30,2019		September 30,2018		September 30,2019		September 30,2018
(in thousands)
Cost of goods sold	$	6	$	4	$	22	$	19
Research and development		61		56		227		205
Selling, general and administrative		193		222		662		708
Total share-based compensation	$	260	$	282	$	911	$	932

Equity awards granted during the three and nine months ended September 30, 2019 and 2018 were as follows:

	Three Months Ended				Nine Months Ended
	September 30,2019		September 30,2018		September 30,2019		September 30,2018
Restricted Stock Units		-		1,000		276,700		206,856
Stock Options		-		-		25,000		-

Non-employee directors Restricted Stock Units (“RSU’s”) vest over one year and options vest over three years and have a six-year exercise period. Employee RSU’s typically vest over four years and employee Non-Qualified stock options typically vest quarterly over 4 years and have a six-year exercise period.

The remaining unamortized expected future equity compensation expense and remaining amortization period associated with unvested option grants, restricted stock awards and restricted stock unit awards at September 30, 2019 are:

	September 30, 2019
Unamortized future equity compensation expense (in thousands)	$	2,612
Remaining weighted average amortization period (in years)		2.58